- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Top 3 therapeutic areas by spending in the U.S. 2014-2018
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Top 3 therapeutic areas by spending in the U.S. 2014-2018
Top 3 therapeutic areas by spending in the U.S. from 2014 to 2018 (in billion U.S. dollars)
by Matej Mikulic,
last edited
Jul 22, 2019
This statistic shows the leading three therapy areas in the United States from 2014 to 2018, based on spending. In 2018, some 58.4 billion U.S. dollars were spent in the area of oncologics, which ranked this therapeutic area second.
Top 3 therapeutic areas by spending in the U.S. from 2014 to 2018 (in billion U.S. dollars)
| Therapeutic area | 2014 | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| Therapeutic area | 2014 | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Jul 22, 2019
This statistic shows the leading three therapy areas in the United States from 2014 to 2018, based on spending. In 2018, some 58.4 billion U.S. dollars were spent in the area of oncologics, which ranked this therapeutic area second.
- Show sources information
- Show publisher information
- Release date
- May 2019
- Region
- United States
- Survey time period
- 2014 to 2018
- Supplementary notes
- Therapy areas are based on proprietary QuintilesIMS definitions. Includes prescription and insulin products sold into chain and independent pharmacies, food store pharmacies, mail service pharmacies, long-term care facilities, hospitals, clinics, and other institutional settings. Excludes OTC.
- Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- May 2019
More information
- Region
- United States
- Survey time period
- 2014 to 2018
- Supplementary notes
- Therapy areas are based on proprietary QuintilesIMS definitions. Includes prescription and insulin products sold into chain and independent pharmacies, food store pharmacies, mail service pharmacies, long-term care facilities, hospitals, clinics, and other institutional settings. Excludes OTC.
- Open this statistic in...
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Cancer in the U.S.
- 89 page/s
- English
- pptx
- Detailed references
Everything On "Cancer in the U.S." in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Cancer in the U.S."
- Overview
The most important statistics
- Distribution of the 10 leading causes of death in the United States in 2017Leading causes of death in the United States 2017
- Percentage of U.S. population who has (or ever had) cancer between 2000 and 2016, by age Percentage of population with cancer in the U.S. 2000-2016
- Estimated number of new cancer cases and deaths in the U.S. for 2019, by gender*Number of new cancer cases and deaths in the U.S. by gender 2019
- Probability of developing invasive cancer in the U.S. for the period 2013-2015, by gender and ageU.S. likelihood of developing invasive cancer 2013-2015 by gender and age
- Incidence rates
The most important statistics
- Incidence rates for cancer in the United States for the period 2011-2015, by gender (per 100,000 population)United States: incidence rates for cancer 2011-2015, by gender
- Incidence rate of cancer in the U.S. for the period 2011-2015, by ethnic group and gender (per 100,000 population)Cancer: incidence rate in the U.S. by ethnic group and gender 2011-2015
- Estimated number of new cancer cases among men in the U.S. in 2009 and 2019, by cancer type*U.S. number of cancer cases among men in 2009 and 2019
- Estimated number of new cancer cases among women in the U.S. in 2009 and 2019, by cancer type*U.S. number of cancer cases among women 2009 and 2019
- U.S. states with the highest cancer incidence rates in 2015 (per 100,000 population)*U.S. states with highest cancer incidence rates 2015
- U.S. states with the lowest cancer incidence rates in 2015 (per 100,000 population)*U.S. states with lowest cancer incidence rates 2015
- Death rates
The most important statistics
- Deaths by cancer in the U.S. from 1950 to 2016 (per 100,000 population)*Deaths by cancer in the U.S. 1950-2016
- Cancer death rates in the United States for the period 2012-2016, by type and gender (per 100,000 population)U.S. death rates from cancer by type and gender 2012-2016
- Cancer death rates in the U.S. for the period 2012-2016, by ethnic group and gender (per 100,000 population)U.S. mortality rates from cancer by ethnic group and gender 2012-2016
- Estimated number of cancer deaths among men in the U.S. in 2009 and 2019, by cancer typeU.S. number of cancer deaths among men 2009 and 2019
- Estimated number of cancer deaths among women in the U.S. in 2009 and 2019, by cancer typeU.S. number of cancer deaths among women 2009 and 2019
- Deaths by prostate cancer in the U.S. from 1950 to 2016 (per 100,000 population)Deaths by prostate cancer in the U.S. 1950-2016
- Deaths by breast cancer in the U.S. from 1950 to 2016 (per 100,000 population)Deaths by breast cancer in the U.S. 1950-2016
- U.S. states with the highest cancer death rates in 2017 (per 100,000 population)*U.S. states with highest cancer death rates 2017
- Probability of surviving
The most important statistics
- Five-year relative cancer survival rates in the U.S. for the period 2008-2014, by type of cancerCancer: 5-year survival rates in the U.S. 2008-2014
- Five-year relative cancer survival rates in the U.S. in periods between 1975 and 2014, by ethnic group Cancer: 5-year survival rates in the U.S. by ethnic group 1975-2014
- Number of U.S. Americans with a history of cancer living between 2004 and 2019 (in millions)U.S. Americans with a history of cancer living 2004-2019
- Risk factors
The most important statistics
- Percentage of U.S. adults who believed the following increased a person's risk of getting cancer as of 2018Leading beliefs about cancer risk factors among U.S. adults as of 2018
- Percentage of U.S. adults with cancer that had select lifestyle habits as of 2018, by ageLifestyle habits of U.S. cancer patients 2018, by age
- Proportion of cancer deaths attributable to cigarette smoking among adults 30 years and older in the U.S. in 2014, by cancer typeShare of cancer deaths due to smoking among U.S. adults 2014, by type
- Rate of overweight and obesity-related invasive cancer cases in the United States in 2014, by cancer type (per 100,000 population)Rate of overweight and obesity-related cancer cases U.S. 2014, by cancer type
- Relative risk for select colorectal cancer risk factors in the U.S. as of 2017*Relative risk for colorectal cancer risk factors in the U.S. as of 2017
- Percentage of U.S. adults who did the following to reduce their risk of getting cancer as of 2018Ways in which U.S. adults reduced their risk of cancer as of 2018
- Cancer drug market
The most important statistics
- Top 20 U.S. therapy areas based on drug spending in 2018 (in billion U.S. dollars)Leading therapy areas for U.S. drug spending 2018
- Top 3 therapeutic areas by spending in the U.S. from 2014 to 2018 (in billion U.S. dollars)Top 3 therapeutic areas by spending in the U.S. 2014-2018
- Number of cancer drugs in development in the United States in select years between 2005 and 2018Number of cancer drugs in development in the U.S. 2005-2018
- Growth of the U.S. oncology therapeutic market from 2013 to 2018, by segment (in billion U.S. dollars)Oncology therapeutic market growth U.S. 2013-2018, by segment
- Miscellaneous
The most important statistics
- Percentage of cancer survivors and persons without a history of cancer who had a high health care out-of-pocket burden in the U.S. from 2011 to 2016, by ageHigh health out-of-pocket burden for cancer survivors U.S. 2011-2016, by age
- Mean annual out-of-pocket health costs for cancer survivors and persons without a history of cancer in the U.S. from 2011 to 2016, by ethnicityAnnual out-of-pocket costs for cancer survivors in the U.S. 2011-2016, by ethnicity
- Percentage of cancer survivors with material and psychological financial hardships in the U.S. in 2011 and 2016, by ageCancer survivor material and psychological financial hardships U.S. 2011-2016, by age
- Number of U.S. states that improved healthy living from 2018 to 2019Number of states that improved healthy living in 2019
- Percentage of adults in the U.S. who had traveled abroad specifically to receive medical treatment as of 2019, by treatment typeMedical treatments U.S. adults had traveled abroad for as of 2019
- Percentage of U.S. adults that felt select achievements were most important to modern medicine as of 2019Most important modern medical achievement according to U.S. adults 2019
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- U.S. spending on specialty medicine by type 2014-2018
- U.S. spending on multiple sclerosis medicine by type 2010-2014
- U.S. spending on biosimilars by type 2014
- U.S. spending growth on new brand specialty medicine by type 2014-2015
- New medicine availability by therapy area worldwide 2013
- Drugs in development with potential to be first-in-class in 2016, by therapeutic area
- Top therapy areas in the U.S. by number of prescriptions 2018
- Global medicine spending share by disease forecast 2020
- Payment method for prescriptions dispensed in the U.S. 2012-2018
- NDA/BLA filing to FDA approval times for new drugs in select disease areas 2006-2015
- Citalopram out of pocket price in the U.S. 2004-2016
- U.S. drug development Phase I to approval success rates 2006-2015 by disease area
- Number of new pharmaceutical drug approvals in South Korea 2014 by therapeutic area
- U.S. NDA/BLA filing approval for new drugs in select disease areas 2006-2015
- Public drug program spending in Canada by top 10 drug classes 2017
- Monthly value of medicament imports into Finland 2018
- Sales value of gastrointestinal agents in Taiwan 2008-2017
- Monthly value of medicament exports from Norway 2017-2018
- Antibacterials for systemic use: consumption in Belgium 2017
- India's medicine and pharmaceutical product imports by value 2000-2019
Studies
- Personalized medicine
- Recent Trends in Hospital Drug Spending and Manufacturer Shortages (2019)
- Prescribed Drug Spending in Canada, 2018
- Patented Medicine Prices Review Board - Annual Report 2017
- Meds Entry Watch 2017
- Patented Medicine Prices Review Board - Annual Report 2016
- Prescribed Drug Spending in Canada, 2017
- Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans: 2...
- Drug Use Among Seniors in Canada, 2016
- Meds Entry Watch 2016
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: 2006 to 2015
- Prescribing for Diabetes, England 2007/08 to 2017/18
- Patented Medicine Prices Review Board - Annual Report 2013
- Patented Medicine Prices Review Board - Annual Report 2014
- Patented Medicine Prices Review Board - Annual Report 2015
Statistics on "Cancer in the U.S."
- Distribution of the 10 leading causes of death in the United States in 2017
- Percentage of U.S. population who has (or ever had) cancer between 2000 and 2016, by age
- Estimated number of new cancer cases and deaths in the U.S. for 2019, by gender*
- Probability of developing invasive cancer in the U.S. for the period 2013-2015, by gender and age
- Incidence rates for cancer in the United States for the period 2011-2015, by gender (per 100,000 population)
- Incidence rate of cancer in the U.S. for the period 2011-2015, by ethnic group and gender (per 100,000 population)
- Estimated number of new cancer cases among men in the U.S. in 2009 and 2019, by cancer type*
- Estimated number of new cancer cases among women in the U.S. in 2009 and 2019, by cancer type*
- U.S. states with the highest cancer incidence rates in 2015 (per 100,000 population)*
- U.S. states with the lowest cancer incidence rates in 2015 (per 100,000 population)*
- Deaths by cancer in the U.S. from 1950 to 2016 (per 100,000 population)*
- Cancer death rates in the United States for the period 2012-2016, by type and gender (per 100,000 population)
- Cancer death rates in the U.S. for the period 2012-2016, by ethnic group and gender (per 100,000 population)
- Estimated number of cancer deaths among men in the U.S. in 2009 and 2019, by cancer type
- Estimated number of cancer deaths among women in the U.S. in 2009 and 2019, by cancer type
- Deaths by prostate cancer in the U.S. from 1950 to 2016 (per 100,000 population)
- Deaths by breast cancer in the U.S. from 1950 to 2016 (per 100,000 population)
- U.S. states with the highest cancer death rates in 2017 (per 100,000 population)*
- U.S. states with the lowest cancer death rates in 2017 (per 100,000 population)*
- Five-year relative cancer survival rates in the U.S. for the period 2008-2014, by type of cancer
- Five-year relative cancer survival rates in the U.S. in periods between 1975 and 2014, by ethnic group
- Number of U.S. Americans with a history of cancer living between 2004 and 2019 (in millions)
- Percentage of U.S. adults who believed the following increased a person's risk of getting cancer as of 2018
- Percentage of U.S. adults with cancer that had select lifestyle habits as of 2018, by age
- Proportion of cancer deaths attributable to cigarette smoking among adults 30 years and older in the U.S. in 2014, by cancer type
- Rate of overweight and obesity-related invasive cancer cases in the United States in 2014, by cancer type (per 100,000 population)
- Relative risk for select colorectal cancer risk factors in the U.S. as of 2017*
- Percentage of U.S. adults who did the following to reduce their risk of getting cancer as of 2018
- Top 20 U.S. therapy areas based on drug spending in 2018 (in billion U.S. dollars)
- Top 3 therapeutic areas by spending in the U.S. from 2014 to 2018 (in billion U.S. dollars)
- Number of cancer drugs in development in the United States in select years between 2005 and 2018
- Growth of the U.S. oncology therapeutic market from 2013 to 2018, by segment (in billion U.S. dollars)
- Percentage of cancer survivors and persons without a history of cancer who had a high health care out-of-pocket burden in the U.S. from 2011 to 2016, by age
- Mean annual out-of-pocket health costs for cancer survivors and persons without a history of cancer in the U.S. from 2011 to 2016, by ethnicity
- Percentage of cancer survivors with material and psychological financial hardships in the U.S. in 2011 and 2016, by age
- Number of U.S. states that improved healthy living from 2018 to 2019
- Percentage of adults in the U.S. who had traveled abroad specifically to receive medical treatment as of 2019, by treatment type
- Percentage of U.S. adults that felt select achievements were most important to modern medicine as of 2019
- Expenditure on specialty medicines in the United States from 2014 to 2018, by type (in billion U.S. dollars)
- Expenditure on multiple sclerosis medicines in the United States from 2010 to 2014, by type (in billion U.S. dollars)
- Expenditure on biosimilars in the United States in 2014, by type (in billion U.S. dollars)*
- Spending growth on new brand specialty medicines in the United States in 2014 and 2015, by type (in billion U.S. dollars)
- New molecular entities availability worldwide as of 2013, by therapy area
- Share of products in clinical development and review that had potential to be first-in-class in 2016, by therapeutic area
- Top 20 therapy areas in the United States in 2018, by number of prescriptions (in millions)
- Forecast of global medicine spending distribution in 2020, by area of disease*
- Distribution of payment types for prescriptions dispensed in the U.S. from 2012 to 2018
- Time from NDA/BLA filings for new drugs to FDA approval in select disease areas in the U.S. between 2006 and 2015
- Citalopram out-of-pocket cost in the U.S. from 2004 to 2016 (in U.S. dollars)*
- Likelihood of approval from Phase I for new drugs in select disease areas in the U.S. between 2006 and 2015
- Number of new drugs receiving approval status in South Korea in 2014, by therapeutic category
- Percent approval for NDA/BLA filings for new drugs in select disease areas in the U.S. between 2006 and 2015
- Top 10 drug classes by total public drug program spending in Canada in 2017 (in million Canadian dollars)*
- Monthly value of medicaments (not packaged for retail sale) imported into Finland from December 2017 to December 2018 (in million U.S. dollars)
- Sales value of gastrointestinal agents in Taiwan between 2008 and 2017 (in billion New Taiwan dollars)
- Monthly value of medicaments (not packaged for retail sale) exported from Norway from April 2017 to April 2018 (in 1,000 U.S. dollars)
- Consumption of antibacterials for systemic use in Belgium in 2017 (in DDD per 1,000 inhabitants per day)
- Value of India's medicine and pharmaceutical product imports from FY 2011 to FY 2019 (in billion Indian rupees)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.